Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes

(2018) Inge M.W. Verberk et al.   ANNALS OF NEUROLOGY

Variability in Blood-Based Amyloid-β Assays: The Need for Consensus on Pre-Analytical Processing

(2018) Andrew D. Watt et al.   JOURNAL OF ALZHEIMERS DISEASE

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

(2018) Harald Hampel et al.   Nature Reviews Neurology

Alzheimer's disease

(2017) C. A. Lane et al.   EUROPEAN JOURNAL OF NEUROLOGY

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome

(2017) Harutsugu Tatebe et al.   Molecular Neurodegeneration

Blood-derived amyloid-β protein induces Alzheimer’s disease pathologies

(2017) X-L Bu et al.   MOLECULAR PSYCHIATRY

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42

(2017) Seong Soo A. An et al.   Alzheimers Research & Therapy

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease

(2017) Min Jeong Wang et al.   Alzheimers Research & Therapy

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts

(2017) Lih-Fen Lue et al.   Frontiers in Aging Neuroscience

The amyloid hypothesis of Alzheimer's disease at 25 years

(2016) Dennis J Selkoe et al.   EMBO Molecular Medicine

Blood Biomarkers for Alzheimer’s Disease: Much Promise, Cautious Progress

(2016) Ashvini Keshavan et al.   Molecular Diagnosis & Therapy

Three screening methods for cognitive dysfunction using the Mini-Mental State Examination and Korean Dementia Screening Questionnaire

(2015) Seong Hye Choi et al.   Geriatrics & Gerontology International

A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy

(2015) Dipanjan Pan et al.   Nanomedicine

A 12-step user guide for analyzing voxel-wise gray matter asymmetries in statistical parametric mapping (SPM)

(2015) Florian Kurth et al.   Nature Protocols

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

(2015) L. G. Apostolova et al.   NEUROLOGY

A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer’s disease with white matter hyperintensities

(2012) Sam-Yeol Ha et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Biofunctionalized Magnetic Nanoparticles for Specifically Detecting Biomarkers of Alzheimer’s Disease in Vitro

(2011) Che-Chuan Yang et al.   ACS Chemical Neuroscience

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

SPM: A history

(2011) John Ashburner   NEUROIMAGE

Differentiating blood samples from scrapie infected and non-infected hamsters by detecting disease-associated prion proteins using Multimer Detection System

(2010) S.S.A. An et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients

(2010) Hyun-Jung Ahn et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration

(2009) Arno Klein et al.   NEUROIMAGE

Oligomeric amyloid   associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

(2009) R. M. Koffie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: Demographic influence and population-based norms (the AGE study)

(2007) Changsu Han et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS